“Barriers to Contraceptive Use in Product Labeling and Practice Guidelines.” D. Grossman, MD, C. Ellertson, PhD, MPA, K. Abuabara, MA, K. Blanchard, MSc, and F. Rivas. American J. Public Health. May 2006.
“Pharmaceutical Companies, Off-Label Promotion and Qui Tam Actions.” F. Rivas, R. Christian, J. Cassel. Business Crimes Bulletin. July 2011.
“How Should FDA and Generic Drug Manufacturers’ respond to FDA’s Proposed Changes to Generic Drug Labeling Rules?” J. Bockus, F. Rivas. Food & Drug Law Policy Forum. Nov. 27, 2013.